Related Experiment Video
Updated: Jun 21, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Disorder, promiscuity, and toxic partnerships
Edward M Marcotte1, Mark Tsechansky
1Department of Chemistry and Biochemistry, University of Texas at Austin, 2500 Speedway, Austin, TX 78712-1064, USA. marcotte@icmb.utexas.edu
Overexpressed genes can be toxic, but the reasons are unclear. This study reveals that protein disorder and promiscuous interactions determine gene dosage sensitivity, explaining oncogene toxicity.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Background:
- Gene overexpression can lead to cellular toxicity, a phenomenon observed across various organisms.
- The underlying molecular mechanisms driving this gene dosage sensitivity have remained largely unexplained.
- Dosage-sensitive genes, when present in abnormal copy numbers, can disrupt cellular homeostasis.
Discussion:
- Intrinsic protein disorder and promiscuous molecular interactions are identified as key factors contributing to gene dosage sensitivity.
- These properties allow proteins to interact with a wider range of cellular components, increasing the likelihood of detrimental interactions upon overexpression.
- This mechanism provides a partial explanation for the toxicity observed in dosage-sensitive oncogenes.
Key Insights:
- Proteins with intrinsically disordered regions are more prone to dosage sensitivity.
- Promiscuous protein interactions exacerbate the negative effects of gene overexpression.
- These findings offer a mechanistic link between protein properties and gene toxicity.
Outlook:
- Further research can explore the role of protein disorder and interaction promiscuity in other genetic disorders.
- Therapeutic strategies could target protein interactions to mitigate the toxicity of overexpressed genes.
- Understanding these mechanisms may aid in the development of novel cancer therapies targeting oncogene addiction.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics and Pharmacogenomics: Overview
Sex Linked Disorders
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genomics
Principles of Pharmacogenetics: Types of Genetic Variants
